Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Germany's Bundestag extends two armed forces missions abroad - 2Iran Used $2 Billion in Crypto to Run Its Militant Proxies in 2025
- 3Vote In favor of Your Favored Distributed computing Administration
- 4Early diagnosis leads King Charles to scale back cancer treatment in the new year
- 5What to know about the hepatitis B shot — and why Trump officials are targeting it
- Grasping the Basics of Business Land Regulation
- The Craft of Do-It-Yourself Home Stylistic layout: Change Your Space
- Artemis II crew cleared to depart Earth orbit, head for moon
- Extraordinary Picks for Home Apparatuses: Making Life Simpler
- Europe must reinvent warfare for ‘era of shocks,’ NATO’s Vandier says
- Twelve injured near Beit Shemesh, reports of shrapnel impact in Eilat as Iran targets Israel
- Yes, NASA's launching Artemis 2 astronauts to the moon on April Fools' Day. It's not a joke.
- 6 Home Cleaning Administrations to Keep Your Home Unblemished
- Aluminum salts emerge as likely target as health officials scrutinize childhood vaccines
